Analystreport

PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "hold" rating re-affirmed by analysts at Barclays PLC. They now have a $51.00 price target on the stock.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com